Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).

Qian, C N; Min, H Q; Lin, H L; Hong, M H; Ye, Y L

Qian, C N; Min, H Q; Lin, H L; Hong, M H; Ye, Y L.

Affiliation

Qian CN; Department of Nasopharyngeal Carcinoma, Tumor Hospital, Sun Yat-sen University of Medical Sciences, (SUMS), Guangzhou, P.R. of China. gzqcnan@public1.guangzhou.gd.cn

J Laryngol Otol ; 112(9): 849-53, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9876375

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Nasopharyngeal Neoplasms/drug therapy; Sesquiterpenes/therapeutic use; Animals; Cyclohexanes; Drug Screening Assays, Antitumor; Male; Mice; Mice, Inbred BALB C; Nasopharyngeal Neoplasms/pathology; Neoplasm Transplantation; Neovascularization, Pathologic/drug therapy; O-(Chloroacetylcarbamoyl)fumagillol; Time Factors; Tumor Cells, Cultured/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Sesquiterpenes / Nasopharyngeal Neoplasms / Antibiotics, Antineoplastic Type of study: Prognostic_studies Language: En Journal: J Laryngol Otol Year: 1998 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links